These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16378057)

  • 1. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Ozgurtas T; Sonmez A; Eyileten T; Yenicesu M; Acikel C; Oguz Y; Ozcan O; Bozlar U; Erbil K; Aslan I; Vural A
    Transplantation; 2005 Dec; 80(12):1660-6. PubMed ID: 16378057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum asymmetric dimethylarginine and endothelial function after renal transplantation.
    Zhang W; Zhou C; Xie J; Chen B; Chang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):289-94. PubMed ID: 19411743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients.
    Esposito C; Grosjean F; Torreggiani M; Maggi N; Esposito V; Migotto C; Mangione F; Tinelli C; Dal Canton A
    Transplant Proc; 2009 Jun; 41(5):1570-3. PubMed ID: 19545681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy.
    Sahin G; Akay OM; Uslu S; Bal C; Yalcin AU; Gulbas Z
    Nephrology (Carlton); 2015 Jun; 20(6):392-8. PubMed ID: 25650527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
    Yilmaz MI; Saglam M; Sonmez A; Caglar K; Cakir E; Kurt Y; Eyileten T; Tasar M; Acikel C; Oguz Y; Vural A; Yenicesu M
    Blood Purif; 2007; 25(4):327-35. PubMed ID: 17709915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
    Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Oguz Y; Aslan I; Vural A; Yenicesu M; Stenvinkel P; Lindholm B; Axelsson J
    Clin Transplant; 2009; 23(2):241-8. PubMed ID: 19402217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.
    Yilmaz MI; Sonmez A; Saglam M; Yaman H; Unal HU; Gok M; Cetinkaya H; Eyileten T; Oguz Y; Sari S; Yildirim AO; Vural A; Carrero JJ; Blanco-Colio LM
    Eur J Clin Invest; 2013 Dec; 43(12):1250-7. PubMed ID: 24112080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects of renal transplantation on endothelial functions and cardiac morphology.
    Ozkurt S; Sahin G; Degirmenci NA; Temiz G; Musmul A; Tek M; Birdane A; Tekin N; Akyuz F; Yalcin AU
    Transplant Proc; 2011 Sep; 43(7):2606-11. PubMed ID: 21911132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
    Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
    Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginines as biomarkers for the kidney transplant management in methylmalonic aciduria.
    Aldámiz-Echevarria L; Andrade F; Llarena M; de Las Heras J; Couce ML
    Nephrology (Carlton); 2015 Aug; 20(8):576-9. PubMed ID: 26194982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
    Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
    PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO
    Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.
    Sahin G; Akay OM; Bal C; Yalcin AU; Gulbas Z
    Clin Nephrol; 2011 Sep; 76(3):218-25. PubMed ID: 21888859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
    Yilmaz MI; Sonmez A; Saglam M; Yaman H; Cayci T; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Yenicesu M; Axelsson J
    Nephrol Dial Transplant; 2010 Oct; 25(10):3250-6. PubMed ID: 20348148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation.
    Saarelainen H; Valtonen P; Punnonen K; Laitinen T; Raitakari OT; Juonala M; Heiskanen N; Lyyra-Laitinen T; Viikari JS; Vanninen E; Heinonen S
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):120-4. PubMed ID: 18093231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
    Vladimirova-Kitova L; Deneva T; Angelova E; Nikolov F; Marinov B; Mateva N
    Clin Physiol Funct Imaging; 2008 Nov; 28(6):417-25. PubMed ID: 18798847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients.
    Dogan I; Dogan T; Yetim M; Kayadibi H; Yilmaz MB; Eser B; Kalcik M; Karavelioglu Y
    Ther Apher Dial; 2018 Apr; 22(2):109-117. PubMed ID: 29205940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
    Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.